{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:28:11Z","timestamp":1760142491442,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.annfar.2014.02.016","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T10:01:57Z","timestamp":1395914517000},"page":"232-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Traitements antifongiques en r\u00e9animation au cours des infections fongiques invasives document\u00e9es ou suspect\u00e9es"],"prefix":"10.1016","volume":"33","author":[{"given":"P.","family":"Massanet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Villiet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Moulaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Roch-Torreilles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Reynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Corne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annfar.2014.02.016_bib0005","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/CCM.0b013e318236f297","article-title":"Systemic antifungal therapy in critically ill patients without invasive fungal infection*","volume":"40","author":"Azoulay","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annfar.2014.02.016_bib0010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/596757","article-title":"Clinical practice guidelines for the management of candidiasis: 2009\u00a0update by the Infectious Diseases Society of America","volume":"48","author":"Pappas","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annfar.2014.02.016_bib0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.annfar.2014.02.016_bib0020","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.01128-10","article-title":"Recent exposure to caspofungin or fluconazole influences the epidemiology of candidemia: a prospective multicenter study involving 2,441\u00a0patients","volume":"55","author":"Lortholary","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.annfar.2014.02.016_bib0025","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","article-title":"A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study","volume":"270","author":"Le Gall","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.annfar.2014.02.016_bib0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.annfar.2014.02.016_bib0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1086\/321811","article-title":"Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey","volume":"33","author":"Blumberg","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annfar.2014.02.016_bib0040","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.1989.00390100145030","article-title":"Risk factors for hospital-acquired candidemia. A matched case-control study","volume":"149","author":"Wey","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.annfar.2014.02.016_bib0045","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","article-title":"Patients at high risk of invasive fungal infections: when and how to treat","volume":"68","author":"Ruping","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.annfar.2014.02.016_bib0050","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1007\/BF01711909","article-title":"Management of deep Candida infection in surgical and intensive care unit patients","volume":"20","author":"British Society for Antimicrobial Chemotherapy Working Party","year":"1994","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.annfar.2014.02.016_bib0055","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annfar.2014.02.016_bib0060","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1097\/CCM.0b013e3181e6cf25","article-title":"Recognition and prevention of nosocomial invasive fungal infections in the intensive care unit","volume":"38","author":"Smith","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annfar.2014.02.016_bib0065","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial","volume":"149","author":"Schuster","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annfar.2014.02.016_bib0070","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1007\/s00134-002-1540-y","article-title":"Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination","volume":"28","author":"Garbino","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.annfar.2014.02.016_bib0075","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00000658-200104000-00010","article-title":"Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients","volume":"233","author":"Pelz","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.annfar.2014.02.016_bib0080","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/01.CCM.0000147726.62304.7F","article-title":"Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients","volume":"32","author":"Piarroux","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annfar.2014.02.016_bib0085","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-007-0270-z","article-title":"Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting","volume":"26","author":"Ostrosky-Zeichner","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.annfar.2014.02.016_bib0090","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archsurg.136.12.1401","article-title":"Temporal assessment of Candida risk factors in the surgical intensive care unit","volume":"136","author":"McKinnon","year":"2001","journal-title":"Arch Surg"},{"key":"10.1016\/j.annfar.2014.02.016_bib0095","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1097\/CCM.0b013e31819dec9b","article-title":"Evolving role of early antifungals in the adult intensive care unit","volume":"37","author":"Lam","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annfar.2014.02.016_bib0100","first-page":"65","article-title":"Septic shock due to candidemia: outcomes and predictors of shock development","volume":"3","author":"Guzman","year":"2011","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.annfar.2014.02.016_bib0105","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.annfar.2014.02.016_bib0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1086\/315193","article-title":"Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole","volume":"181","author":"Marr","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.annfar.2014.02.016_bib0115","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1056\/NEJM199110313251803","article-title":"Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole","volume":"325","author":"Wingard","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annfar.2014.02.016_bib0120","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.medmal.2010.06.007","article-title":"Traitements antifongiques des candid\u00e9mies chez les patients non neutrop\u00e9niques\u00a0: \u00e9valuation des pratiques en r\u00e9animation","volume":"40","author":"Massanet","year":"2010","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.annfar.2014.02.016_bib0125","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-143-12-200512200-00004","article-title":"Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis","volume":"143","author":"Golan","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annfar.2014.02.016_bib0130","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.ophtha.2011.01.038","article-title":"Fungal eye disease at a tertiary care center: the utility of routine inpatient consultation","volume":"118","author":"Dozier","year":"2011","journal-title":"Ophthalmology"}],"container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765814000872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765814000872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:20:31Z","timestamp":1760091631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0750765814000872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0750765814000872"],"URL":"https:\/\/doi.org\/10.1016\/j.annfar.2014.02.016","relation":{},"ISSN":["0750-7658"],"issn-type":[{"type":"print","value":"0750-7658"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitements antifongiques en r\u00e9animation au cours des infections fongiques invasives document\u00e9es ou suspect\u00e9es","name":"articletitle","label":"Article Title"},{"value":"Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annfar.2014.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Soci\u00e9t\u00e9 fran\u00e7aise d\u2019anesth\u00e9sie et de r\u00e9animation (Sfar). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}